The global injectable drugs delivery market size is expected to reach around US$ 1,223.6 billion by 2030 and is expected to grow at an impressive double-digit rate of 9.05% from 2022 to 2030.
One of the significant factors driving the growth of global injectable drugs delivery market is growing prevalence of cancer.
The study includes drivers and restraints of this market. The study provides an analysis of the global injectable drugs delivery market for the period 2017-2030, wherein 2022 to 2030 is the forecast period and 2021 is considered as the base year.
Report Scope of the Infant Injectable Drugs Delivery Market
| Report Coverage | Details |
| Market Size by 2030 | USD 1,223.6 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 9.05% |
| Largest Market | North America |
| Fastest Growing Market | Europe |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
Our Free Sample Reports Includes:
- In-depth Industry Analysis, Introduction, Overview, and COVID-19 Pandemic Outbreak.
- Impact Analysis 150+ Pages Research Report (Including latest research).
- Provide chapter-wise guidance on request 2022 Updated Regional Analysis with Graphical Representation of Trends, Size, & Share, Includes Updated List of figures and tables.
- Updated Report Includes Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis by using Precedence Research methodology.
Download Free Sample Copy Here (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1760
Research Methodology
A unique research methodology has been utilized to conduct comprehensive research on the growth of the global injectable drugs delivery market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the draw conclusions. Secondary sources referred to by analysts during the production of the global market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.
These primary and secondary sources provided exclusive information during interviews, which serves as a validation from mattress topper industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global injectable drugs delivery market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped to estimates the future prospects of the global market more reliable and accurate.
Why should you invest in this report?
If you are aiming to enter the global injectable drugs delivery market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for injectable drugs delivery are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global injectable drugs delivery market include:
- Becton
- Dickinson and Company
- Pfizer Inc.
- Teva Pharmaceuticals Industries Ltd.
- Eli Lilly and Company
- Baxter International, Inc.
- Sandoz
- Terumo
- Schott AG
- Gerresheimer
- Ypsomed
- Bespak
- B. Braun Melsungen
Market Segmentation:
By Type
- Devices
- Formulations
By Formulation Packaging
- Ampules
- Vials
- Cartridges
- Bottles
By Therapeutic Application
- Auto-immune diseases
- Hormonal Disorders
- Orphan Diseases
- Oncology
- Other Therapeutic Applications
By Usage Pattern
- Curative Care
- Immunization
- Other Usage Pattern
By Site of Administration
- Skin
- Circulatory/Musculoskeletal
- Organs
- Central Nervous System
By Distribution Channel
- Hospitals
- Retail Pharmacy Stores
By Facility of Use
- Hospitals & Clinics
- Home Care Settings
- Other Facilities of Use
Regional Analysis:
The geographical analysis of the global injectable drugs delivery market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global injectable drugs delivery Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global injectable drugs delivery market in 2030?
- What is the expected CAGR for the injectable drugs delivery market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global injectable drugs delivery market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Injectable Drugs Delivery Market, By Type
7.1. Injectable Drugs Delivery Market, by Type, 2022-2030
7.1.1. Devices
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Formulations
7.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Injectable Drugs Delivery Market, By Formulation Packaging
8.1. Injectable Drugs Delivery Market, by Formulation Packaging, 2022-2030
8.1.1. Ampules
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Vials
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Cartridges
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.3. Bottles
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Injectable Drugs Delivery Market, By Therapeutic Application
9.1. Injectable Drugs Delivery Market, by Therapeutic Application, 2022-2030
9.1.1. Auto-immune diseases
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Hormonal Disorders
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Orphan Diseases
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Oncology
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Other Therapeutic Applications
9.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Injectable Drugs Delivery Market, By Usage Pattern
10.1. Injectable Drugs Delivery Market, by Usage Pattern, 2022-2030
10.1.1. Curative Care
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Immunization
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Other Usage Pattern
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Injectable Drugs Delivery Market, By Site of Administration
11.1. Injectable Drugs Delivery Market, by Site of Administration, 2022-2030
11.1.1. Skin
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Circulatory/Musculoskeletal
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Organs
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Central Nervous System
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Injectable Drugs Delivery Market, By Distribution Channel
12.1. Injectable Drugs Delivery Market, by Distribution Channel, 2022-2030
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Retail Pharmacy Stores
12.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Injectable Drugs Delivery Market, By Facility of Use
13.1. Injectable Drugs Delivery Market, by Facility of Use, 2022-2030
13.1.1. Hospitals & Clinics
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. Home Care Settings
13.1.2.1. Market Revenue and Forecast (2017-2030)
13.1.2. Other Facilities of Use
13.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 14. Global Injectable Drugs Delivery Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Type (2017-2030)
14.1.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.1.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.1.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.1.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.1.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.1.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.1.8. U.S.
14.1.8.1. Market Revenue and Forecast, by Type (2017-2030)
14.1.8.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.1.8.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.1.8.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.1.8.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.1.8.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.1.8.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Type (2017-2030)
14.1.9.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.1.9.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.1.9.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.1.9.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.1.9.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.1.9.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2. Europe
14.2.1. Market Revenue and Forecast, by Type (2017-2030)
14.2.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.2.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.2.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.2.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.2.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.2.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Type (2017-2030)
14.2.8.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.2.8.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.2.8.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.2.8.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.2.8.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.2.8.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.9. Germany
14.2.9.1. Market Revenue and Forecast, by Type (2017-2030)
14.2.9.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.2.9.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.2.9.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.2.9.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.2.9.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.2.9.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.10. France
14.2.10.1. Market Revenue and Forecast, by Type (2017-2030)
14.2.10.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.2.10.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.2.10.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.2.10.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.2.10.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.2.10.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.11. Rest of Europe
14.2.11.1. Market Revenue and Forecast, by Type (2017-2030)
14.2.11.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.2.11.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.2.11.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.2.11.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.2.11.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.2.11.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Type (2017-2030)
14.3.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.3.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.3.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.3.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.3.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.3.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.8. India
14.3.8.1. Market Revenue and Forecast, by Type (2017-2030)
14.3.8.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.3.8.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.3.8.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.3.8.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.3.8.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.3.8.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.9. China
14.3.9.1. Market Revenue and Forecast, by Type (2017-2030)
14.3.9.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.3.9.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.3.9.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.3.9.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.3.9.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.3.9.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.10. Japan
14.3.10.1. Market Revenue and Forecast, by Type (2017-2030)
14.3.10.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.3.10.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.3.10.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.3.10.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.3.10.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.3.10.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.11. Rest of APAC
14.3.11.1. Market Revenue and Forecast, by Type (2017-2030)
14.3.11.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.3.11.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.3.11.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.3.11.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.3.11.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.3.11.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Type (2017-2030)
14.4.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.4.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.4.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.4.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.4.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.4.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.8. GCC
14.4.8.1. Market Revenue and Forecast, by Type (2017-2030)
14.4.8.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.4.8.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.4.8.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.4.8.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.4.8.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.4.8.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.9. North Africa
14.4.9.1. Market Revenue and Forecast, by Type (2017-2030)
14.4.9.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.4.9.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.4.9.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.4.9.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.4.9.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.4.9.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.10. South Africa
14.4.10.1. Market Revenue and Forecast, by Type (2017-2030)
14.4.10.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.4.10.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.4.10.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.4.10.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.4.10.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.4.10.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.11. Rest of MEA
14.4.11.1. Market Revenue and Forecast, by Type (2017-2030)
14.4.11.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.4.11.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.4.11.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.4.11.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.4.11.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.4.11.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Type (2017-2030)
14.5.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.5.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.5.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.5.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.5.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.5.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.5.8. Brazil
14.5.8.1. Market Revenue and Forecast, by Type (2017-2030)
14.5.8.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.5.8.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.5.8.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.5.8.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.5.8.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.5.8.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Type (2017-2030)
14.5.9.2. Market Revenue and Forecast, by Formulation Packaging (2017-2030)
14.5.9.3. Market Revenue and Forecast, by Therapeutic Application (2017-2030)
14.5.9.4. Market Revenue and Forecast, by Usage Pattern (2017-2030)
14.5.9.5. Market Revenue and Forecast, by Site of Administration (2017-2030)
14.5.9.6. Market Revenue and Forecast, by Facility of Use (2017-2030)
14.5.9.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
Chapter 15. Company Profiles
15.1. Becton
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Dickinson and Company
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Pfizer Inc.
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Teva Pharmaceuticals Industries Ltd.
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Eli Lilly and Company
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Baxter International, Inc.
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Sandoz
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Terumo
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Schott AG
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Gerresheimer
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
0 Comments